2-hydroxycinnamaldehyde, 3541-42-2

Articles:

PubMed:	A new coumarin and cytotoxic activities of constituents from Cinnamomum cassia.
PubMed:	LRP1-dependent pepsin clearance induced by 2'-hydroxycinnamaldehyde attenuates breast cancer cell invasion.
PubMed:	[Chemical constituents from Elephantopus tomentosus].
PubMed:	Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
PubMed:	2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells.
PubMed:	Induction of tumor cell death through targeting tubulin and evoking dysregulation of cell cycle regulatory proteins by multifunctional cinnamaldehydes.
PubMed:	2'-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway.
PubMed:	2-Hydroxycurcuminoid induces apoptosis of human tumor cells through the reactive oxygen species-mitochondria pathway.
PubMed:	Differential antiproliferation effect of 2'-benzoyloxycinnamaldehyde in K-ras-transformed cells via downregulation of thiol antioxidants.
PubMed:	2'-Hydroxycinnamaldehyde targets low-density lipoprotein receptor-related protein-1 to inhibit lipopolysaccharide-induced microglial activation.
PubMed:	Platelet anti-aggregation activities of compounds from Cinnamomum cassia.
PubMed:	2'-Hydroxycinnamaldehyde shows antitumor activity against oral cancer in vitro and in vivo in a rat tumor model.
PubMed:	Transport and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in Caco-2 cells.
PubMed:	Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention.
PubMed:	Structure-activity analysis of 2'-modified cinnamaldehyde analogues as potential anticancer agents.
PubMed:	Plasma pharmacokinetics and metabolism of the antitumour drug candidate 2'-benzoyloxycinnamaldehyde in rats.
PubMed:	Synthesis and biological evaluation of cinnamyl compounds as potent antitumor agents.
PubMed:	Apoptosis induction of 2'-hydroxycinnamaldehyde as a proteasome inhibitor is associated with ER stress and mitochondrial perturbation in cancer cells.
PubMed:	2-hydroxycinnamaldehyde inhibits SW620 colon cancer cell growth through AP-1 inactivation.
PubMed:	Delayed occurrence of H-ras12V-induced hepatocellular carcinoma with long-term treatment with cinnamaldehydes.
PubMed:	Synthesis and biological evaluation of dimeric cinnamaldehydes as potent antitumor agents.
PubMed:	Induction of apoptotic cell death by 2'-hydroxycinnamaldehyde is involved with ERK-dependent inactivation of NF-kappaB in TNF-alpha-treated SW620 colon cancer cells.
PubMed:	Inhibitory effect of 2'-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-kappa B activation in RAW 264.7 cells.
PubMed:	Physicochemical properties of 2'-benzoyloxycinnamaldehyde.
PubMed:	2'-benzoyloxycinnamaldehyde induces apoptosis in human carcinoma via reactive oxygen species.
PubMed:	Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase.
PubMed:	Constituents of the essential oil of the Cinnamomum cassia stem bark and the biological properties.
PubMed:	Inhibition of human tumor growth by 2'-hydroxy- and 2'-benzoyloxycinnamaldehydes.
PubMed:	Synthesis and in vitro cytotoxicity of cinnamaldehydes to human solid tumor cells.
PubMed:	Cinnamaldehyde inhibits lymphocyte proliferation and modulates T-cell differentiation.
PubMed:	2'-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia.